Lacutamab Data Boost Prospects For Innate Pharma
Potential Cutaneous T-Cell Lymphoma Therapy
The French biotech has presented positive Phase II data on lacutamab in mycosis fungoides at the EORTC-CLTG meeting in Madrid which looks to have de-risked the asset.
